Articles published by IGC Pharma, Inc.
![](https://mms.businesswire.com/media/20240826027126/en/2225256/5/IGC_Pharma%2C_Inc.jpg)
IGC Announces Results of its 2024 Annual Stockholders Meeting
August 26, 2024
From IGC Pharma, Inc.
Via Business Wire
Tickers
IGC
![](https://mms.businesswire.com/media/20240822040435/en/2222128/5/IGC_Pharma%2C_Inc.jpg)
IGC Pharma Announces Research Demonstrating New Molecule IGC-1C Targets Tau Protein in Alzheimer's Disease
August 22, 2024
From IGC Pharma, Inc.
Via Business Wire
Tickers
IGC
![](https://mms.businesswire.com/media/20240808215193/en/2211827/5/IGC_Pharma%2C_Inc.jpg)
IGC Pharma Reports First Quarter Fiscal 2025 Results
August 08, 2024
From IGC Pharma, Inc.
Via Business Wire
Tickers
IGC
![](https://mms.businesswire.com/media/20240718012019/en/2189398/5/IGC_Pharma%2C_Inc.jpg)
![](https://mms.businesswire.com/media/20240709006689/en/2180051/5/IGC_Pharma%2C_Inc.jpg)
Preclinical Analyses of TGR-63 Demonstrate Blood-Brain Barrier Permeability and Safety Profile
July 09, 2024
From IGC Pharma, Inc.
Via Business Wire
Tickers
IGC
![](https://mms.businesswire.com/media/20240625363805/en/2168855/5/IGC_Pharma%2C_Inc.jpg)
![](https://mms.businesswire.com/media/20240624423552/en/2168791/5/IGC_Pharma%2C_Inc.jpg)
![](https://mms.businesswire.com/media/20240618553406/en/2162681/5/IGC_Pharma%2C_Inc.jpg)
![](https://mms.businesswire.com/media/20240610337877/en/2153989/5/IGC_Pharma%2C_Inc.jpg)
![](https://mms.businesswire.com/media/20240416790137/en/2099199/5/IGC_Pharma%2C_Inc.jpg)
![](https://mms.businesswire.com/media/20240409688531/en/2092684/5/IGC_Pharma%2C_Inc.jpg)
IGC Pharma Adds Advisor in Artificial Intelligence
April 09, 2024
From IGC Pharma, Inc.
Via Business Wire
Tickers
IGC
![](https://mms.businesswire.com/media/20240320069009/en/2073862/5/IGC_Pharma%2C_Inc.jpg)
IGC Pharma Announces Positive Interim Results for IGC-AD1 in Reducing Alzheimer’s Agitation
March 20, 2024
From IGC Pharma, Inc.
Via Business Wire
Tickers
IGC
![](https://mms.businesswire.com/media/20240320471778/en/2073417/5/IGC_Pharma%2C_Inc.jpg)
IGC PHARMA Announces its Participation at the Benzinga Virtual Healthcare Summit 2024
March 20, 2024
From IGC Pharma, Inc.
Via Business Wire
Tickers
IGC
![](https://mms.businesswire.com/media/20240312241127/en/2064402/5/IGC_Pharma%2C_Inc.jpg)
IGC Pharma (IGC): Healthcare Leader Terry Lierman Joins Board to Advance Alzheimer’s Pipeline
March 12, 2024
From IGC Pharma, Inc.
Via Business Wire
Tickers
IGC
![](https://mms.businesswire.com/media/20240228605279/en/2048779/5/IGC_Pharma%2C_Inc.jpg)
Promising Results: TGR-63 Enhances Memory in Alzheimer's Mouse Model
February 28, 2024
From IGC Pharma, Inc.
Via Business Wire
Tickers
IGC
![](https://mms.businesswire.com/media/20240223060837/en/2043687/5/IGC_Pharma%2C_Inc.jpg)
IGC Pharma Announces Equity Analyst Coverage by Ascendiant with a “Buy” Recommendation and $3.00 Price Target
February 23, 2024
From IGC Pharma, Inc.
Via Business Wire
Tickers
IGC
![](https://mms.businesswire.com/media/20240216772877/en/2037504/5/IGC_Pharma%2C_Inc.jpg)
IGC Pharma Reports Third Quarter Fiscal 2024 Results
February 16, 2024
From IGC Pharma, Inc.
Via Business Wire
Tickers
IGC
![](https://mms.businesswire.com/media/20240201187807/en/2017183/5/IGC_Pharma%2C_Inc.jpg)
IGC Pharma Announces TGR-63 Reduces Agitation in Alzheimer's Mouse Model
February 01, 2024
From IGC Pharma, Inc.
Via Business Wire
Tickers
IGC
![](https://mms.businesswire.com/media/20240123339435/en/2006288/5/IGC_Pharma%2C_Inc.jpg)
IGC Pharma Breakthrough: Preclinical Trial Data Shows TGR-63 Reduces Plaque in Alzheimer’s
January 23, 2024
From IGC Pharma, Inc.
Via Business Wire
Tickers
IGC
![](https://mms.businesswire.com/media/20240117772816/en/2000967/5/IGC_Pharma%2C_Inc.jpg)
IGC Pharma Activates ClinCloud, One of 12 Sites in Ongoing Phase 2b Alzheimer’s Trial
January 17, 2024
From IGC Pharma, Inc.
Via Business Wire
Tickers
IGC
![](https://mms.businesswire.com/media/20231219216406/en/1974368/5/IGC_Pharma%2C_Inc.jpg)
Patent Granted to IGC Pharma for Groundbreaking Drug Formulation to Treat Agitation in Alzheimer’s
December 19, 2023
From IGC Pharma, Inc.
Via Business Wire
Tickers
IGC
![](https://mms.businesswire.com/media/20231213574375/en/1968744/5/IGC_Pharma%2C_Inc.jpg)
![](https://mms.businesswire.com/media/20231206728858/en/1961550/5/IGC_Pharma%2C_Inc.jpg)
IGC Pharma Announces Collaboration to Integrate AI into Clinical Trials
December 06, 2023
From IGC Pharma, Inc.
Via Business Wire
Tickers
IGC
![](https://mms.businesswire.com/media/20231121375305/en/1950321/5/IGC_Pharma%2C_Inc.jpg)
IGC Pharma Announces Master Agreement with Leading South American University to Advance AI Initiatives
November 21, 2023
From IGC Pharma, Inc.
Via Business Wire
Tickers
IGC
![](https://mms.businesswire.com/media/20231113501857/en/1942492/5/IGC_Pharma%2C_Inc.jpg)
IGC Pharma Reports Second Quarter Fiscal 2024 Results
November 13, 2023
From IGC Pharma, Inc.
Via Business Wire
Tickers
IGC
![](https://mms.businesswire.com/media/20231019014295/en/1920733/5/IGC_Pharma%2C_Inc.jpg)
IGC Pharma Granted European Patent for Groundbreaking Cannabinoid-Based Pain Topical Relief Therapy
October 19, 2023
From IGC Pharma, Inc.
Via Business Wire
Tickers
IGC
![](https://mms.businesswire.com/media/20230821175299/en/1871516/5/IGC_Pharma%2C_Inc.jpg)
IGC Announces Results of its 2023 Annual Stockholders Meeting
August 21, 2023
From IGC Pharma, Inc.
Via Business Wire
Tickers
IGC
![](https://mms.businesswire.com/media/20230814741620/en/1865885/5/IGC_Pharma%2C_Inc.jpg)
![](https://mms.businesswire.com/media/20230802100326/en/1856842/5/IGC_Pharma%2C_Inc.jpg)
IGC Pharma Expands Phase 2 Trial of IGC-AD1 to Include the University of Puerto Rico
August 02, 2023
From IGC Pharma, Inc.
Via Business Wire
Tickers
IGC
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.